G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
54.70
-0.20 (-0.36%)
Apr 2, 2025, 1:13 PM CST
G&E Herbal Biotechnology Revenue
In the year 2024, G&E Herbal Biotechnology had annual revenue of 249.03M TWD with 37.25% growth. G&E Herbal Biotechnology had revenue of 67.04M in the quarter ending December 31, 2024, with 37.25% growth.
Revenue
249.03M
Revenue Growth
+37.25%
P/S Ratio
12.96
Revenue / Employee
6.39M
Employees
39
Market Cap
3.23B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 249.03M | 67.59M | 37.25% |
Dec 31, 2023 | 181.44M | 116.84M | 180.84% |
Dec 31, 2022 | 64.61M | 40.04M | 162.94% |
Dec 31, 2021 | 24.57M | -3.66M | -12.96% |
Dec 31, 2020 | 28.23M | 10.68M | 60.82% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Oneness Biotech | 117.93M |
Lumosa Therapeutics | 39.15M |
Pegavision | 6.82B |
Polaris Group | 107.00M |